Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 729 evidences · page 42 / 70

2 840 000 casesIn 2019, nearly 2.84 million children under 19 years of age were living with HIV globally.

NigeriaVIH/sidaobservé 2019publié 2024MedicinePubMeddocument de 6 observations

3,01 odds_ratioHIV/AIDS was associated with alcohol use disorder (AUD) with an odds ratio of 3.01 (95% CI: 1.67–7.01).

Nigeriaalcohol use disorder (AUD) · VIH/sidapublié 2020The Pan African medical journalPubMeddocument de 5 observations

5,4 %The prevalence of HIV-related ocular disorders among persons living with HIV/AIDS in Osun State, Nigeria was 5.4%.

NigeriaVIH/sidapublié 2026BMC ophthalmologyPubMeddocument de 9 observations

66,7 %Among long-distance truck drivers in Ekiti State, Nigeria, two-thirds were interested in HIV self-testing.

NigeriaVIH/sidaobservé 2019publié 2021The Nigerian postgraduate medical journalPubMeddocument de 7 observations

2 018 082 personsA total of 2,018,082 persons were tested for HIV in Akwa Ibom State, Nigeria from April 2017 to March 2021.

NigeriaVIH/sidaobservé April 2017 to March 2021publié 2022PloS onePubMeddocument de 7 observations

WHO stage 1 and CD4 ≥ 200 cells/mm³ were strongly associated with recent HIV infection (p < 0.001).

NigeriaVIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 3 observations

4,55 odds_ratioNon-pregnant females had an odds ratio of 4.55 for loss to follow-up among patients commencing antiretroviral therapy.

NigeriaVIH/sidaobservé 2004 to 2017publié 2019AIDS research and therapyPubMeddocument de 11 observations

1,74 aORPrevious low-level viremia was associated with an adjusted odds ratio of 1.74 (95% CI: 1.56–1.93) for subsequent virologic nonsuppression among people with HIV on tenofovir, lamivudine, and dolutegravir (TLD).

NigeriaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 8 observations

87 %Virologic suppression using a cut-off of less than 50 copies/ml was 87% among persons with HIV who initiated ART between January 2016 and September 2022 in Nigeria.

NigeriaVIH/sidapublié 2023AIDS (London, England)PubMeddocument de 4 observations

Significant clusters of HIV infection among people who inject drugs (PWID) in Nigeria were confined to the North Central and South South regions.

NigeriaVIH/sidaobservé October 1, 2016 to September 30, 2017publié 2021JMIR public health and surveillancePubMeddocument de 6 observations

20,7 %20.7% of HIV-positive male partners had disclosed their HIV status to all partners.

NigeriaVIH/sidapublié 2020Current HIV researchPubMeddocument de 5 observations

39 %39% of the ART clients investigated were aged 25–34 at their last ART pick-up date, and 32% of those aged 25–34 had interrupted treatment.

NigeriaVIH/sidaobservé 2000-2020publié 2021BMC public healthPubMeddocument de 12 observations

0,02 aORPaediatrics on salvage antiretroviral regimen had an adjusted odds ratio of 0.02 for interruption of antiretroviral therapy.

NigeriaVIH/sidapublié 2021BMC public healthPubMeddocument de 12 observations

53,7 %The study included 65 (53.7%) females and 56 (46.3%) males among HIV-infected children on HAART.

NigeriaVIH/sidapublié 2025African health sciencesPubMeddocument de 7 observations

57,6 %Overall, only 57.6% of respondents possessed a comprehensive knowledge of HIV.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 7 observations

0,44 odds_ratioAmong HIV-positive individuals, the TGF-β1 rs1800470 polymorphism (GG vs AA) was associated with a reduced risk of prevalent chronic kidney disease, with an adjusted odds ratio of 0.44.

Nigeriamaladie rénale chronique · VIH/sidapublié 2020American journal of kidney diseases : the official journal of the National Kidney FoundatiPubMeddocument de 7 observations

13 286 testsFrom January 2020 to September 2021, 13,286 HIV tests were completed for people who inject drugs in Bayelsa and Niger States, Nigeria.

NigeriaVIH/sidaobservé January 2020 to September 2021publié 2023Global health, science and practicePubMeddocument de 7 observations

47,2 %The overall prevalence of HIV disclosure (full or partial) to children in Abuja, Nigeria was 47.2%.

NigeriaVIH/sidaobservé 2016publié 2020Nigerian journal of clinical practicePubMeddocument de 5 observations

55,6 %More than half (149/268; 55.6%) of interviewed patients were not on antiretroviral therapy.

NigeriaVIH/sidapublié 2019PloS onePubMeddocument de 8 observations

105 personsVisual impairment was present in 105 (23.3%) of the participants.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 9 observations

27,3 %27.3% of the 99 patients with NTM isolates were living with HIV.

NigeriaVIH/sidapublié 2026BMC infectious diseasesPubMeddocument de 10 observations

39 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Nigeria était de 39 % en 2012.

NigeriaVIH/sidaobservé 2012HAL · Unilimdocument de 747 observations

0,69 aORMales among older adolescents living with HIV in Nigeria were less likely to achieve viral suppression, with an adjusted odds ratio of 0.69.

NigeriaVIH/sidapublié 2020BMJ global healthPubMeddocument de 7 observations

65 000 000 USDThe annual costs of providing PMTCT at current coverage rates in Nigeria range from US$ 65 million in 2020 to US$ 72 million in 2025.

NigeriaVIH/sidaobservé 2020 to 2025publié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

77,1 %Most deaths (77.1%) among HIV/AIDS admissions occurred within the first ten days of hospitalization.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 11 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.